BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2004
View Archived Issues
In vivo characterization of a rapid-acting thyroid hormone derivative
Read More
Chemokine microbicide formulation effective against HIV-1 in macaques
Read More
Influenza vaccine from Aventis now available for shipping
Read More
Dual neuroprotection from oxygen and nitrogen reactive species
Read More
PEP-005 shows high selectivity against leukemia
Read More
New phase I study of AT-1001 for Fabry's disease
Read More
Phase I studies begin for ABT-894 for neuropathic pain
Read More
OrthoLogic completes acquisition of Chrysalis BioTechnology
Read More
New indication approved for Hyzaar
Read More
European recommendation for extended dosing of Aranesp
Read More
GlycoGenesys enters agreements to close on funding from institutions
Read More
Yakult Honsha and Taiho to copromote oxaliplatin in Japan
Read More
Portola licenses Millennium's Factor Xa inhibitor program
Read More
Five series of chemokine CCR5 antagonists presented by GSK
Read More
AstraZeneca presents novel GSK-3 inhibitors for AD and other uses
Read More
Japanese researchers prepare and test a new antineoplastic antibiotic
Read More
New KDR and FGFR inhibitors with potential in solid tumor therapy
Read More
New epothilone derivatives in early development at Novartis
Read More
New glucagon antagonists discovered by Novo Nordisk scientists
Read More
Novel PAI-1 inhibitors produced by the microorganism Stachybotris atra
Read More
Human multidrug resistance protein 1 targeted in malignant cells
Read More
Frovatriptan provides relief for menstrual associated migraine
Read More
Merck & Co. and DOV enter agreement for triple uptake inhibitor development
Read More
NPS to promote Amgen's Kineret to rheumatologists
Read More
Approvable letter for ZyLET
Read More
Sinovac's phase I SARS study progresses
Read More
Dosing begins in phase I study of the thrombin inhibitor ARC-183
Read More